Arvinas and Pfizer are the first to take a PROteolysis TArgeting Chimera (PROTAC) therapy across the FDA finish line, opening the door …
Category:
Fitness
A surprise interim trial miss in ivonescimab’s closely watched Harmoni-3 trial has sent Summit Therapeutics’ shares tumbling, casting a shadow over the …
Published April 30, 2026 06:00AM Before you jet off to morning Masters swim or throw on a pair of running shoes, take …
As Eli Lilly gets off to the races with the launch of its flagship oral GLP-1 Foundayo, the Indianapolis drugmaker—and at least …
- Fitness
AstraZeneca’s camizestrant ambitions stumble as FDA panel rejects novel oral SERD proposal
by AiNewsBlogby AiNewsBlogThe FDA’s Oncologic Drugs Advisory Committee (ODAC) on Thursday voted 6 to 3 that AstraZeneca has not demonstrated its oral SERD camizestrant …
Are Europeans faster? Is triathlon too expensive? What really saves you on race day? Columnist Tim Heming dives into the tri topics …
- Fitness
Bayer earns FDA untitled letter for Nubeqa’s ‘attention-grabbing visuals’
by AiNewsBlogby AiNewsBlogThe FDA has reprimanded Bayer for the “attention-grabbing visuals” and “frequent scene changes” in ads for the company’s prostate cancer drug Nubeqa. …
In an interview with Pharmacy Times, Jiyeon Oh, MD, first author and staff at the Department of Medicine at Kyung Hee University …
- Fitness
What Pro Triathletes Change When Training Time is Limited — Triathlete
by AiNewsBlogby AiNewsBlogPublished April 29, 2026 10:13AM Life has a habit of throwing curveballs at triathletes. Whether it’s a new job, a new baby, …
The FDA today announced a new initiative to allow its reviewers to access information from clinical trials in real time, with two …
Novartis CEO Vas Narasimhan says Europe needs a “complete rethink” of how it prices its drugs, warning that the entrance of new …
Published April 28, 2026 06:00AM When I started training for triathlons 15 years ago, I’d never participated in an organized swim practice, …
Boehringer Ingelheim’s glucagon/GLP-1 dual agonist has driven 16.6% weight loss at Week 76 of a phase 3 study. While the result fell short …
Both Seaport Therapeutics and Hemab Therapeutics are hoping to bring in around $180 million each from their public listings this week, in …
- Fitness
Fierce Pharma Asia—Merck’s PD-1xVEGF data; Zai Lab’s global view; Kailera’s record IPO
by AiNewsBlogby AiNewsBlogMerck & Co. unveiled the much-anticipated first look at its PD-1xVEGF bispecific data. China’s Zai Lab is looking to go global. With …
- Fitness
Reigning T100 Champion Hayden Wilde Dominates in Singapore Heat with 6-Minute Victory
by AiNewsBlogby AiNewsBlogLast year’s untouchable star returns to Singapore and picks up where he left off, opening the 2026 men’s T100 season with a …
Roche’s Genentech unit is launching a new multimedia campaign aimed at sharing the stories of people living with diabetes and the disease’s …
Welcome to this week’s Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the industry. Please send the …
Getting faster doesn’t have to put you into debt. Find out how the little things can make a big difference. Listen to …
After a series of regulatory and clinical setbacks for Sanofi’s tolebrutinib, the French pharma has scored a victory for the multiple sclerosis …
- Fitness
Compass, Usona and Transcend score FDA national priority vouchers amid Trump administration’s psychedelic push
by AiNewsBlogby AiNewsBlogThe FDA is awarding national priority vouchers to Compass Pathways, Transcend Therapeutics and the Usona Institute as the Trump administration looks for …
With triathlon pre-season in full swing in most parts of the country, so is our gear testing team. Here’s the gear they …
Patients’ confidence in their ability to find answers about health questions and make informed decisions has plummeted in the past year, according to …
Kurma Partners has closed its fourth biotech venture capital fund after raising 215 million euros ($252 million) to support European startups. Paris-based …
No time? No Problem. These quick-hit brick workouts get you a 30-minute triathlon fix to help you maximize your lunch hour (and …
While Big Pharmas embarked on a frenzy of acquisitions over recent weeks, Roche’s CEO has explained to Fierce Biotech why the Swiss …
After AbbVie earlier this year pledged a whopping $100 billion in U.S. R&D and capital investments over the next decade, the company …
Show your love for the Earth with planet-conscious ways to swim, bike, run – and shop. (Photo: Challenge Family) Published April 22, …
- Fitness
FDA Approves Once-Daily HIV Regimen Combining Doravirine and Islatravir
by AiNewsBlogby AiNewsBlogThe FDA has approved doravirine/islatravir (Idvynso; Merck), a once-daily, oral, 2-drug fixed-dose combination tablet for the treatment of HIV-1 infection in adults …
Pfizer’s chief strategist, Andrew Baum, M.D., is leaving his post two years after pivoting from a career-long tenure as a biopharma equity …
